ORCID as entered in ROS

Select Publications
2024, 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate', Clinical Microbiology and Infection, 30, pp. 743 - 754, http://dx.doi.org/10.1016/j.cmi.2024.01.029
,2024, 'Corticosteroids in septic shock secondary to community acquired pneumonia: clarity mixed with uncertainty', Lancet Respiratory Medicine, 12, pp. 338 - 339, http://dx.doi.org/10.1016/S2213-2600(23)00470-8
,2024, 'Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis', Lancet Respiratory Medicine, 12, pp. 237 - 246, http://dx.doi.org/10.1016/S2213-2600(23)00417-4
,2024, 'Fluid therapy in diabetic ketoacidosis', Current Opinion in Clinical Nutrition and Metabolic Care, 27, pp. 178 - 183, http://dx.doi.org/10.1097/MCO.0000000000001005
,2024, 'Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis', Acta Anaesthesiologica Scandinavica, 68, pp. 146 - 166, http://dx.doi.org/10.1111/aas.14346
,2024, 'EARLY PERSISTENT LYMPHOPENIA AND RISK OF DEATH IN CRITICALLY ILL PATIENTS WITH AND WITHOUT SEPSIS', Shock, 61, pp. 197 - 203, http://dx.doi.org/10.1097/SHK.0000000000002284
,2024, 'A Genome-Wide Association Study of Serum Metabolite Profiles in Septic Shock Patients', Critical Care Explorations, 6, pp. E1030, http://dx.doi.org/10.1097/CCE.0000000000001030
,2024, 'Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial', Lancet Regional Health Southeast Asia, 20, http://dx.doi.org/10.1016/j.lansea.2023.100293
,2024, 'Selective digestive tract decontamination in critically ill adults with acute brain injuries: a post hoc analysis of a randomized clinical trial', Intensive Care Medicine, 50, pp. 56 - 67, http://dx.doi.org/10.1007/s00134-023-07261-y
,2024, 'Estimating Aggregate Capacity of Connected DERs and Forecasting Feeder Power Flow With Limited Data Availability', IEEE OPEN ACCESS JOURNAL OF POWER AND ENERGY, 11, pp. 266 - 279, http://dx.doi.org/10.1109/OAJPE.2024.3413606
,2024, 'General Multi-Phase Element-Based Load Flow for AC-DC Power Systems', IEEE TRANSACTIONS ON POWER DELIVERY, 39, pp. 1634 - 1646, http://dx.doi.org/10.1109/TPWRD.2024.3376535
,2024, 'Pilot Randomized Clinical Trial of a Passive Non-invasive Positive End-Expiratory Pressure (PEEP) Device for Delivering Positive Pressure Therapy Compared to Standard Care in Non-critically Ill Patients With COVID-19', Cureus, 16, pp. e71267, http://dx.doi.org/10.7759/cureus.71267
,2024, 'Sizing Merchant Energy Storage for Maximum Revenues Considering Net Metering and Ancillary Services', IEEE ACCESS, 12, pp. 2210 - 2223, http://dx.doi.org/10.1109/ACCESS.2023.3347338
,2023, 'Adaptive designs in critical care trials: a simulation study', BMC Medical Research Methodology, 23, http://dx.doi.org/10.1186/s12874-023-02049-6
,2023, 'REVISE: re-evaluating the inhibition of stress erosions in the ICU—statistical analysis plan for a randomized trial', Trials, 24, http://dx.doi.org/10.1186/s13063-023-07794-z
,2023, 'Sepsis-coded hospitalisations and associated costs in Australia: a retrospective analysis', BMC Health Services Research, 23, http://dx.doi.org/10.1186/s12913-023-10223-1
,2023, 'The Association Between Days Alive and Out of Hospital and Health-Related Quality of Life in Patients With Sepsis', Chest Critical Care, 1, http://dx.doi.org/10.1016/j.chstcc.2023.100024
,2023, 'REVISE: R e-Ev aluating the i nhibition of S tress e rosions in the ICU: A randomised trial protocol', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-075588
,2023, 'Acute Kidney Injury With Empirical Antibiotics for Sepsis', JAMA, 330, pp. 1531 - 1533, http://dx.doi.org/10.1001/jama.2023.18591
,2023, 'Impact of 1-hour and 3-hour sepsis time bundles on antibiotic use in emergency departments in Queensland, Australia: a before-and-after cohort study', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-072167
,2023, 'Sex differences in pain expressed by patients across diverse disease states: individual patient data meta-analysis of 33,957 participants in 10 randomized controlled trials', Pain, 164, pp. 1666 - 1676, http://dx.doi.org/10.1097/j.pain.0000000000002884
,2023, 'Sodium chloride or plasmalyte-148 for patients presenting to emergency departments with diabetic ketoacidosis: A nested cohort study within a multicentre, cluster, crossover, randomised, controlled trial', EMA Emergency Medicine Australasia, 35, pp. 657 - 663, http://dx.doi.org/10.1111/1742-6723.14198
,2023, 'Lymphopenia in sepsis—an acquired immunodeficiency?', Immunology and Cell Biology, 101, pp. 535 - 544, http://dx.doi.org/10.1111/imcb.12611
,2023, 'Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?', Lancet, 401, pp. 1474 - 1476, http://dx.doi.org/10.1016/S0140-6736(23)00587-1
,2023, 'Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19', Nejm Evidence, 2, http://dx.doi.org/10.1056/EVIDoa2200293
,2023, 'Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial', Acta Anaesthesiologica Scandinavica, 67, pp. 195 - 205, http://dx.doi.org/10.1111/aas.14167
,2023, 'A Randomized Trial of Nafamostat for Covid-19.', NEJM Evid, 2, pp. EVIDoa2300132, http://dx.doi.org/10.1056/EVIDoa2300132
,2023, 'AC Transmission Network Expansion Planning Using the Line-Wise Model for Representing Meshed Transmission Networks', IEEE TRANSACTIONS ON POWER SYSTEMS, 38, pp. 2204 - 2223, http://dx.doi.org/10.1109/TPWRS.2022.3183549
,2023, 'Capacity Market for Distribution System Operator - With Reliability Transactions - Considering Critical Loads and Microgrids', IEEE TRANSACTIONS ON POWER DELIVERY, 38, pp. 902 - 916, http://dx.doi.org/10.1109/TPWRD.2022.3200869
,2023, 'Comparative Analysis and Optimal Operation of an On-Grid and Off-Grid Solar Photovoltaic-Based Electric Vehicle Charging Station', ENERGIES, 16, http://dx.doi.org/10.3390/en16248086
,2023, 'Coordinated optimization model for solar PV systems integrated into DC distribution networks', JOURNAL OF ENGINEERING-JOE, 2023, http://dx.doi.org/10.1049/tje2.12295
,2023, 'Distribution System Topology Identification via Efficient MILP-Based WLAV State Estimation', IEEE TRANSACTIONS ON POWER SYSTEMS, 38, pp. 75 - 84, http://dx.doi.org/10.1109/TPWRS.2022.3164600
,2023, 'Fast QC Relaxation of the Optimal Power Flow Using the Line-Wise Model for Representing Meshed Transmission Networks', IEEE ACCESS, 11, pp. 2775 - 2786, http://dx.doi.org/10.1109/ACCESS.2022.3233633
,2023, 'Fast SDP Relaxation of the Optimal Power Flow Using the Line-Wise Model for Representing Meshed Transmission Networks', IEEE TRANSACTIONS ON POWER SYSTEMS, 38, pp. 3814 - 3827, http://dx.doi.org/10.1109/TPWRS.2022.3200970
,2023, 'Fuzzy optimisation model of an incremental capacity auction formulation with greenhouse gas consideration', IET SMART GRID, 6, pp. 124 - 135, http://dx.doi.org/10.1049/stg2.12065
,2023, 'Identification and ranking of customers with energy theft using hypothesis tests', ELECTRIC POWER SYSTEMS RESEARCH, 225, http://dx.doi.org/10.1016/j.epsr.2023.109862
,2023, 'Learning-Assisted Variables Reduction Method for Large-Scale MILP Unit Commitment', IEEE OPEN ACCESS JOURNAL OF POWER AND ENERGY, 10, pp. 245 - 258, http://dx.doi.org/10.1109/OAJPE.2023.3247989
,2023, 'Machine Learning-Additional Decision Constraints for Improved MILP Day-Ahead Unit Commitment Method', IEEE ACCESS, 11, pp. 111976 - 111990, http://dx.doi.org/10.1109/ACCESS.2023.3323594
,2023, 'MILP Model for Optimal Day-Ahead PDS Scheduling Considering TSO-DSO Interconnection Power Flow Commitment Under Uncertainty', IEEE TRANSACTIONS ON POWER SYSTEMS, 38, pp. 1932 - 1945, http://dx.doi.org/10.1109/TPWRS.2022.3228838
,2023, 'On the Potential of ChatGPT to Generate Distribution Systems for Load Flow Studies Using OpenDSS', IEEE TRANSACTIONS ON POWER SYSTEMS, 38, pp. 5965 - 5968, http://dx.doi.org/10.1109/TPWRS.2023.3315543
,2023, 'Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock.', NEJM Evid, 2, pp. EVIDoa2300034, http://dx.doi.org/10.1056/EVIDoa2300034
,2022, 'A Comparison of the Commonly Used Surrogate Markers for Citrate Accumulation and Toxicity during Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation', Blood Purification, 51, pp. 997 - 1005, http://dx.doi.org/10.1159/000524129
,2022, 'ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06929-y
,2022, 'Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-14226-6
,2022, 'Recruitment characteristics of randomised trials in critical care: A systematic review', Clinical Trials, 19, pp. 673 - 680, http://dx.doi.org/10.1177/17407745221123248
,2022, 'Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19', BLOOD, 140, http://dx.doi.org/10.1182/blood-2022-168448
,2022, 'Association between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis', JAMA, 328, pp. 1922 - 1934, http://dx.doi.org/10.1001/jama.2022.19709
,2022, 'Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review', Clinical Pharmacokinetics, 61, pp. 1331 - 1343, http://dx.doi.org/10.1007/s40262-022-01170-x
,2022, 'Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India: A Cross-sectional Study', Chest, 161, pp. 1543 - 1554, http://dx.doi.org/10.1016/j.chest.2021.12.673
,2022, 'Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2021-059540
,